Xennovate Medical LLC is categorized under Adhesives and Sealants Manufacturers in Madison, WI .
Xennovate Medical LLC was established in 0, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Adhesives and Sealants Manufacturers business, which does work in the B2B market, and is classified as a Adhesives and Sealants Manufacturers, under code number 3255200 by the NAICS.
If you are seeking more information, feel free to contact Neil Kosterman, Partner at the company’s single location by writing to 709 Orion Trail, Madison, Wisconsin WI 53718 or by phoning (608) 448-6345. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Xennovate Medical LLC |
| Contact Person: | Neil Kosterman, Partner |
| Address: | 709 Orion Trail, Madison, Wisconsin 53718 |
| Phone Number: | (608) 448-6345 |
| Website Address: | xennovate.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Adhesives and Sealants Manufacturers |
| SIC Code: | 2891 |
| NAICS Code: | 3255200 |
| Share This Business: |
Xennovate Medical LLC was started in 0 to provide professional Adhesives and Sealants Manufacturers under the SIC code 2891 and NAICS code 3255200. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Neil Kosterman, Partner for inquiries that concern Xennovate Medical LLC by calling the company number (608) 448-6345, as your correspondence is most welcome. Additionally, the physical location of the single location of Xennovate Medical LLC can be found at the coordinates 43.087338,-89.277925 as well as the street address 709 Orion Trail in Madison, Wisconsin 53718.
For its online presence, you may visit Xennovate Medical LLC’s website at xennovate.com and engage with its social media outlets through on Twitter and on Facebook.